Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Social distancing

- PMLiVE

Regeneron’s COVID-19 antibody cocktail reduces viral load and alleviates symptoms

Investigational treatment also helped patients recover faster

- PMLiVE

GSK chief exec ‘optimistic’ COVID-19 vaccine could be available next year

GSK is currently partnering with Sanofi on a COVID-19 vaccine project

- PMLiVE

Moderna’s COVID-19 vaccine generates strong immune response in older adults

New data builds on initial data read-out announced in August

- PMLiVE

Inovio hit with FDA hold on COVID-19 vaccine trial

Trial placed on hold after FDA raises questions over delivery device

- PMLiVE

Researchers call on Pfizer to delay COVID-19 vaccine application

Reports that the company could seek regulatory approval in October have raised safety concerns

- PMLiVE

Phase 1/2a results for J&J’s COVID-19 vaccine show early promise

Vaccine produced neutralising antibodies in 98% of participants

AstraZeneca AZ

EU will shoulder certain liability costs in AZ COVID-19 vaccine deal

Low-cost deal will see the EU assume responsibility for side-effect claims

- PMLiVE

J&J advances COVID-19 vaccine into phase 3 testing

News comes after last week's announcement from Novavax on its launch of a UK-based phase 3 trial

- PMLiVE

Novavax starts first phase 3 COVID-19 vaccine trial in the UK

Trial is set to enrol up to 10,000 participants aged 18-84

Session 4: Systems Innovation Insight and Thinking

Impetus Digital

- PMLiVE

UK COVID-19 vaccine ‘challenge trials’ could intentionally infect participants with virus

UK human ‘challenge trial’ programme would be a world first

- PMLiVE

Relief Therapeutics seeks US emergency approval for COVID-19 drug

If granted, EUA would give approval for use in severely ill patients with no other treatment options

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links